Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1978 Jul-Aug;51(4):457–468.

Environmental Chemicals and Nervous System Dysfunction 1

Terri Damstra
PMCID: PMC2595611  PMID: 87062

Abstract

Selected examples of associations between nervous system diseases and exposures to occupational and environmental chemicals have been reviewed. Recent outbreaks of human neurotoxicity from both wellknown and previously unknown toxicants reemphasize the need for the medical community to give increased attention to chemical causes of nervous system dysfunction.

Full text

PDF
457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Rahman M. S., Hetland L. B., Couri D. Toxicity and metabolism of methyl n-butyl ketone. Am Ind Hyg Assoc J. 1976 Feb;37(2):95–102. doi: 10.1080/0002889768507418. [DOI] [PubMed] [Google Scholar]
  2. Aldridge W. N., Barnes J. M., Johnson M. K. Studies on delayed neurotoxicity produced by some organophosphorus compounds. Ann N Y Acad Sci. 1969;160(1):314–322. doi: 10.1111/j.1749-6632.1969.tb15851.x. [DOI] [PubMed] [Google Scholar]
  3. Allen N., Mendell J. R., Billmaier D. J., Fontaine R. E., O'Neill J. Toxic polyneuropathy due to methyl n-butyl ketone. An industrial outbreak. Arch Neurol. 1975 Apr;32(4):209–218. doi: 10.1001/archneur.1975.00490460025001. [DOI] [PubMed] [Google Scholar]
  4. Amin-Zaki L., Elhassani S., Majeed M. A., Clarkson T. W., Doherty R. A., Greenwood M. Intra-uterine methylmercury poisoning in Iraq. Pediatrics. 1974 Nov;54(5):587–595. [PubMed] [Google Scholar]
  5. Anku V. D., Harris J. W. Peripheral neuropathy and lead poisoning in a child with sickle-cell anemia. Case report and review of the literature. J Pediatr. 1974 Sep;85(3):337–340. doi: 10.1016/s0022-3476(74)80111-3. [DOI] [PubMed] [Google Scholar]
  6. BIDSTRUP P. L., BONNELL J. A., BECKETT A. G. Paralysis following poisoning by a new organic phosphorus insecticide (mipafox); report on two cases. Br Med J. 1953 May 16;1(4819):1068–1072. doi: 10.1136/bmj.1.4819.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BRADLEY J. E., BAUMGARTNER R. J. Subsequent mental development of children with lead encephalopathy, as related to type of treatment. J Pediatr. 1958 Sep;53(3):311–315. doi: 10.1016/s0022-3476(58)80217-6. [DOI] [PubMed] [Google Scholar]
  8. Bakir F., Damluji S. F., Amin-Zaki L., Murtadha M., Khalidi A., al-Rawi N. Y., Tikriti S., Dahahir H. I., Clarkson T. W., Smith J. C. Methylmercury poisoning in Iraq. Science. 1973 Jul 20;181(4096):230–241. doi: 10.1126/science.181.4096.230. [DOI] [PubMed] [Google Scholar]
  9. Bicknell J., Clayton B. E., Delves H. T. Lead in mentally retarded children. J Ment Defic Res. 1968 Dec;12(4):282–293. doi: 10.1111/j.1365-2788.1968.tb00268.x. [DOI] [PubMed] [Google Scholar]
  10. Billmaier D., Allen N., Craft B., Williams N., Epstein S., Fontaine R. Peripheral neuropathy in a coated fabrics plant. J Occup Med. 1974 Oct;16(10):665–671. [PubMed] [Google Scholar]
  11. CHISOLM J. J., Jr, HARRISON H. E. The exposure of children to lead. Pediatrics. 1956 Dec;18(6):943–958. [PubMed] [Google Scholar]
  12. CREMER J. E. Biochemical studies on the toxicity of tetraethyl lead and other organo-lead compounds. Br J Ind Med. 1959 Jul;16:191–199. doi: 10.1136/oem.16.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cavanagh J. B. The significance of the "dying back" process in experimental and human neurological disease. Int Rev Exp Pathol. 1964;3:219–267. [PubMed] [Google Scholar]
  14. Cianchetti C., Abbritti G., Perticoni G., Siracusa A., Curradi F. Toxic polyneuropathy of shoe-industry workers. A study of 122 cases. J Neurol Neurosurg Psychiatry. 1976 Dec;39(12):1151–1161. doi: 10.1136/jnnp.39.12.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cohen C. J., Bowers G. N., Lepow M. L. Epidemiology of lead poisoning. A comparison between urban and rural children. JAMA. 1973 Dec 17;226(12):1430–1433. [PubMed] [Google Scholar]
  16. Cohn W. J., Boylan J. J., Blanke R. V., Fariss M. W., Howell J. R., Guzelian P. S. Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial. N Engl J Med. 1978 Feb 2;298(5):243–248. doi: 10.1056/NEJM197802022980504. [DOI] [PubMed] [Google Scholar]
  17. DAVIGNON L. F., SAINT-PIERRE J., CHAREST G., TOURANGEAU F. J. A STUDY OF THE CHRONIC EFFECTS OF INSECTICIDES IN MAN. Can Med Assoc J. 1965 Mar 20;92:597–602. [PMC free article] [PubMed] [Google Scholar]
  18. Davenport J. G., Farrell D. F., Sumi M. "Giant axonal neuropathy" caused by industrial chemicals: neurofilamentous axonal masses in man. Neurology. 1976 Oct;26(10):919–923. doi: 10.1212/wnl.26.10.919. [DOI] [PubMed] [Google Scholar]
  19. David O., Clark J., Voeller K. Lead and hyperactivity. Lancet. 1972 Oct 28;2(7783):900–903. doi: 10.1016/s0140-6736(72)92534-2. [DOI] [PubMed] [Google Scholar]
  20. David O., Clark J., Voeller K. Lead and hyperactivity. Lancet. 1972 Oct 28;2(7783):900–903. doi: 10.1016/s0140-6736(72)92534-2. [DOI] [PubMed] [Google Scholar]
  21. De la Burdé B., Choate M. S., Jr Does asymptomatic lead exposure in children have latent sequelae? J Pediatr. 1972 Dec;81(6):1088–1091. doi: 10.1016/s0022-3476(72)80236-1. [DOI] [PubMed] [Google Scholar]
  22. DiVincenzo G. D., Kaplan C. J., Dedinas J. Characterization of the metabolites of methyl n-butyl ketone, methyl iso-butyl ketone, and methyl ethyl ketone in guinea pig serum and their clearance. Toxicol Appl Pharmacol. 1976 Jun;36(3):511–522. doi: 10.1016/0041-008x(76)90230-1. [DOI] [PubMed] [Google Scholar]
  23. Erenberg G., Rinsler S. S., Fish B. G. Lead neuropathy and sickle cell disease. Pediatrics. 1974 Oct;54(4):438–441. [PubMed] [Google Scholar]
  24. Evans H. L., Laties V. G., Weiss B. Behavioral effects of mercury and methylmercury. Fed Proc. 1975 Aug;34(9):1858–1867. [PubMed] [Google Scholar]
  25. Feldman R. G., Haddow J., Kopito L., Schwachman H. Altered peripheral nerve conduction velocity. Chronic lead intoxication in children. Am J Dis Child. 1973 Jan;125(1):39–41. doi: 10.1001/archpedi.1973.04160010021005. [DOI] [PubMed] [Google Scholar]
  26. Fisher J. R. Guillain-Barré syndrome following organophosphate poisoning. JAMA. 1977 Oct 31;238(18):1950–1951. [PubMed] [Google Scholar]
  27. Fullerton P. M. Chronic peripheral neuropathy produced by lead poisoning in guinea-pigs. J Neuropathol Exp Neurol. 1966 Apr;25(2):214–236. doi: 10.1097/00005072-196604000-00003. [DOI] [PubMed] [Google Scholar]
  28. GERSHON S., SHAW F. H. Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet. 1961 Jun 24;1(7191):1371–1374. doi: 10.1016/s0140-6736(61)92004-9. [DOI] [PubMed] [Google Scholar]
  29. Gaines T. B. Acute toxicity of pesticides. Toxicol Appl Pharmacol. 1969 May;14(3):515–534. doi: 10.1016/0041-008x(69)90013-1. [DOI] [PubMed] [Google Scholar]
  30. HOLMSTEDT B. Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol Rev. 1959 Sep;11:567–688. [PubMed] [Google Scholar]
  31. Hansen D. J., Wilson A. J., Nimmo del W. R., Schimmel S. C., Bahner L. H., Huggett R. Kepone: hazard to aquatic organisms. Science. 1976 Aug 13;193(4253):528–528. doi: 10.1126/science.193.4253.528. [DOI] [PubMed] [Google Scholar]
  32. Hicks R. M. Air-borne lead as an environmental toxin. A review. Chem Biol Interact. 1972 Nov;5(6):361–390. doi: 10.1016/0009-2797(72)90075-0. [DOI] [PubMed] [Google Scholar]
  33. Johnson M. K. Mechanism of protection against the delayed neurotoxic effects of organophosphorus esters. Fed Proc. 1976 Jan;35(1):73–74. [PubMed] [Google Scholar]
  34. Johnson M. K. Organophosphorus esters causing delayed neurotoxic effects: mechanism of action and structure activity studies. Arch Toxicol. 1975 Dec 18;34(4):259–288. doi: 10.1007/BF00353848. [DOI] [PubMed] [Google Scholar]
  35. Johnson M. K. The delayed neuropathy caused by some organophosphorus esters: mechanism and challenge. CRC Crit Rev Toxicol. 1975 Jun;3(3):289–316. doi: 10.3109/10408447509079861. [DOI] [PubMed] [Google Scholar]
  36. KURLAND L. T., FARO S. N., SIEDLER H. Minamata disease. The outbreak of a neurologic disorder in Minamata, Japan, and its relationship to the ingestion of seafood contaminated by mercuric compounds. World Neurol. 1960 Nov;1:370–395. [PubMed] [Google Scholar]
  37. Klein M. C., Sayre J. W., Kotok D. Lead poisoning. Current status of the problem facing pediatricians. Am J Dis Child. 1974 Jun;127(6):805–807. doi: 10.1001/archpedi.1974.02110250031004. [DOI] [PubMed] [Google Scholar]
  38. Konat G., Clausen J. Triethyllead-induced hypomyelination in the developing rat forebrain. Exp Neurol. 1976 Jan;50(1):124–133. doi: 10.1016/0014-4886(76)90240-5. [DOI] [PubMed] [Google Scholar]
  39. Korobkin R., Asbury A. K., Sumner A. J., Nielsen S. L. Glue-sniffing neuropathy. Arch Neurol. 1975 Mar;32(3):158–162. doi: 10.1001/archneur.1975.00490450038004. [DOI] [PubMed] [Google Scholar]
  40. Kotok D. Development of children with elevated blood lead levels: a controlled study. J Pediatr. 1972 Jan;80(1):57–61. doi: 10.1016/s0022-3476(72)80453-0. [DOI] [PubMed] [Google Scholar]
  41. Lampert P. W., Schochet S. S. Electron microscopic observations on experimental spongy degeneration of the cerebellar white matter. J Neuropathol Exp Neurol. 1968 Apr;27(2):210–220. doi: 10.1097/00005072-196804000-00003. [DOI] [PubMed] [Google Scholar]
  42. Lampert P. W., Schochet S. S., Jr Demyelination and remyelination in lead neuropathy. Electron microscopic studies. J Neuropathol Exp Neurol. 1968 Oct;27(4):527–545. [PubMed] [Google Scholar]
  43. Landrigan P. J., Whitworth R. H., Baloh R. W., Staehling N. W., Barthel W. F., Rosenblum B. F. Neuropsychological dysfunction in children with chronic low-level lead absorption. Lancet. 1975 Mar 29;1(7909):708–712. doi: 10.1016/s0140-6736(75)91627-x. [DOI] [PubMed] [Google Scholar]
  44. Lansdown R. G., Shepherd J., Clayton B. E., Delves H. T., Graham P. J., Turner W. C. Blood-lead levels, behaviour, and intelligence. A population study. Lancet. 1974 Mar 30;1(7857):538–541. doi: 10.1016/s0140-6736(74)92718-4. [DOI] [PubMed] [Google Scholar]
  45. Le Quesne P. M., Damluji S. F., Rustam H. Electrophysiological studies of peripheral nerves in patients with organic mercury poisoning. J Neurol Neurosurg Psychiatry. 1974 Mar;37(3):333–339. doi: 10.1136/jnnp.37.3.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Levin H. S., Rodnitzky R. L., Mick D. L. Anxiety associated with exposure to organophosphate compounds. Arch Gen Psychiatry. 1976 Feb;33(2):225–228. doi: 10.1001/archpsyc.1976.01770020061010. [DOI] [PubMed] [Google Scholar]
  47. Lilis R., Blumberg W. E., Fischbein A., Eisinger J., Diamond S., Anderson H. A., Selikoff I. J. Lead effects among secondary lead smelter workers with blood lead levels below 80 microgram/100 ml. Arch Environ Health. 1977 Nov-Dec;32(6):256–266. doi: 10.1080/00039896.1977.10667292. [DOI] [PubMed] [Google Scholar]
  48. MELLINS R. B., JENKINS C. D. Epidemiological and psychological study of lead poisoning in children. J Am Med Assoc. 1955 May 7;158(1):15–20. doi: 10.1001/jama.1955.02960010017004. [DOI] [PubMed] [Google Scholar]
  49. MORRIS C. E., HEYMAN A., POZEFSKY T. LEAD ENCEPHALOPATHY CAUSED BY INGESTION OF ILLICITLY DISTILLED WHISKEY. Neurology. 1964 Jun;14:493–499. doi: 10.1212/wnl.14.6.493. [DOI] [PubMed] [Google Scholar]
  50. Magos L. Mercury and mercurials. Br Med Bull. 1975 Sep;31(3):241–245. doi: 10.1093/oxfordjournals.bmb.a071293. [DOI] [PubMed] [Google Scholar]
  51. Mallov J. S. MBK neuropathy among spray painters. JAMA. 1976 Apr 5;235(14):1455–1457. [PubMed] [Google Scholar]
  52. Matsumura M., Inoue N., Onishi A., Santa T., Goto I. [Polyneuropathy due to glue-sniffing--2 cases involving identical twins]. Rinsho Shinkeigaku. 1972 Jun;12(6):290–296. [PubMed] [Google Scholar]
  53. Maugh T. H., 2nd Chemicals: how many are there? Science. 1978 Jan 13;199(4325):162–162. doi: 10.1126/science.199.4325.162. [DOI] [PubMed] [Google Scholar]
  54. Metcalf D. R., Holmes J. H. VII. Toxicology and physiology. EEG, psychological, and neurological alterations in humans with organophosphorus exposure. Ann N Y Acad Sci. 1969;160(1):357–365. doi: 10.1111/j.1749-6632.1969.tb15857.x. [DOI] [PubMed] [Google Scholar]
  55. Namba T., Nolte C. T., Jackrel J., Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med. 1971 Apr;50(4):475–492. doi: 10.1016/0002-9343(71)90337-8. [DOI] [PubMed] [Google Scholar]
  56. Paulson G. W., Waylonis G. W. Polyneuropathy due to n-hexane. Arch Intern Med. 1976 Aug;136(8):880–882. [PubMed] [Google Scholar]
  57. Pedraza M. A., Anzinger F. Lead encephalopathy. Report of a case associated with industrial exposure. Ohio State Med J. 1974 May;70(5):319–321. [PubMed] [Google Scholar]
  58. Prineas J. The pathogenesis of dying-back polyneuropathies. I. An ultrastructural study of experimental tri-ortho-cresyl phosphate intoxication in the cat. J Neuropathol Exp Neurol. 1969 Oct;28(4):571–597. doi: 10.1097/00005072-196910000-00003. [DOI] [PubMed] [Google Scholar]
  59. Pueschel S. M., Kopito L., Schwachman H. Children with an increased lead burden. A screening and follow-up study. JAMA. 1972 Oct;222(4):462–466. [PubMed] [Google Scholar]
  60. Reich G. A., Berner W. H. Aerial application accidents 1963 to 1966. An analysis of the principal factors. Arch Environ Health. 1968 Nov;17(5):776–784. doi: 10.1080/00039896.1968.10665319. [DOI] [PubMed] [Google Scholar]
  61. Rodnitzky R. L. Occupational exposure to organophosphate pesticides: a neurobehavioral study. Arch Environ Health. 1975 Feb;30(2):98–103. doi: 10.1080/00039896.1975.10666651. [DOI] [PubMed] [Google Scholar]
  62. Rustam H., Hamdi T. Methyl mercury poisoning in Iraq. A neurological study. Brain. 1974 Sep;97(3):500–510. [PubMed] [Google Scholar]
  63. SANDERS L. W., Sr TETRAETHYLLEAD INTOXICATION. Arch Environ Health. 1964 Feb;8:270–277. doi: 10.1080/00039896.1964.10663667. [DOI] [PubMed] [Google Scholar]
  64. SMITH H. D., BAEHNER R. L., CARNEY T., MAJORS W. J. The sequelae of pica with and without lead poisoning. A comparison of the sequelae five or more years later. I. Clinical and laboratory observations. Am J Dis Child. 1963 Jun;105:609–616. doi: 10.1001/archpedi.1963.02080040611011. [DOI] [PubMed] [Google Scholar]
  65. SMITH H. V., SPALDING J. M. Outbreak of paralysis in Morocco due to ortho-cresyl phosphate poisoning. Lancet. 1959 Dec 5;2(7110):1019–1021. doi: 10.1016/s0140-6736(59)91486-2. [DOI] [PubMed] [Google Scholar]
  66. Sauer R. M., Zook B. C., Garner F. M. Demyelinating encephalomyelopathy associated with lead poisoning in nonhuman primates. Science. 1970 Sep 11;169(3950):1091–1093. doi: 10.1126/science.169.3950.1091. [DOI] [PubMed] [Google Scholar]
  67. Schaumburg H. H., Spencer P. S. Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain. 1976 Jun;99(2):183–192. doi: 10.1093/brain/99.2.183. [DOI] [PubMed] [Google Scholar]
  68. Schaumburg H. H., Spencer P. S. Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science. 1978 Jan 13;199(4325):199–200. doi: 10.1126/science.413192. [DOI] [PubMed] [Google Scholar]
  69. Schaumburg H. H., Spencer P. S. The neurology and neuropathology of the occupational neuropathies. J Occup Med. 1976 Nov;18(11):739–742. doi: 10.1097/00043764-197611000-00010. [DOI] [PubMed] [Google Scholar]
  70. Schaumburg H. H., Wiśniewski H. M., Spencer P. S. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol. 1974 Apr;33(2):260–284. doi: 10.1097/00005072-197404000-00006. [DOI] [PubMed] [Google Scholar]
  71. Schaumburg H. H., Wiśniewski H. M., Spencer P. S. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol. 1974 Apr;33(2):260–284. doi: 10.1097/00005072-197404000-00006. [DOI] [PubMed] [Google Scholar]
  72. Schlaepfer W. W. Experimental lead neuropathy: a disease of the supporting cells in the peripheral nervous system. J Neuropathol Exp Neurol. 1969 Jul;28(3):401–418. [PubMed] [Google Scholar]
  73. Seppäläinen A. M., Tola S., Hernberg S., Kock B. Subclinical neuropathy at "safe" levels of lead exposure. Arch Environ Health. 1975 Apr;30(4):180–183. doi: 10.1080/00039896.1975.10666672. [DOI] [PubMed] [Google Scholar]
  74. Shirabe T., Tsuda T., Terao A., Araki S. Toxic polyneuropathy due to glue-sniffing. Report of two cases with a light and electron-microscopic study of the peripheral nerves and muscles. J Neurol Sci. 1974 Jan;21(1):101–113. doi: 10.1016/0022-510x(74)90110-5. [DOI] [PubMed] [Google Scholar]
  75. Skerfving S. Methylmercury exposure, mercury levels in blood and hair, and health status in Swedes consuming contaminated fish. Toxicology. 1974 Mar;2(1):3–23. doi: 10.1016/0300-483x(74)90038-9. [DOI] [PubMed] [Google Scholar]
  76. Spencer P. S., Schaumburg H. H. Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry. 1975 Aug;38(8):771–775. doi: 10.1136/jnnp.38.8.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Spencer P. S., Schaumburg H. H., Raleigh R. L., Terhaar C. J. Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol. 1975 Apr;32(4):219–222. doi: 10.1001/archneur.1975.00490460035002. [DOI] [PubMed] [Google Scholar]
  78. Towfighi J., Gonatas N. K., Pleasure D., Cooper H. S., McCree L. Glue sniffer's neuropathy. Neurology. 1976 Mar;26(3):238–243. doi: 10.1212/wnl.26.3.238. [DOI] [PubMed] [Google Scholar]
  79. VORA D. D., DASTUR D. K., BRAGANCA B. M., PARIHAR L. M., IYER C. G., FONDEKAR R. B., PRABHAKARAN K. Toxic polyneuritis in Bombay due to ortho-cresyl-phosphate poisoning. J Neurol Neurosurg Psychiatry. 1962 Aug;25:234–242. doi: 10.1136/jnnp.25.3.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Vostal J. J., Clarkson T. W. Mercury as an environmental hazard. J Occup Med. 1973 Aug;15(8):649–656. [PubMed] [Google Scholar]
  81. Wadia R. S., Sadagopan C., Amin R. B., Sardesai H. V. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry. 1974 Jul;37(7):841–847. doi: 10.1136/jnnp.37.7.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Whitfield C. L., Ch'ien L. T., Whitehead J. D. Lead encephalopathy in adults. Am J Med. 1972 Mar;52(3):289–298. doi: 10.1016/0002-9343(72)90016-2. [DOI] [PubMed] [Google Scholar]
  83. Wickersham C. W., 3rd, Fredericks E. J. Toxic polyneuropathy secondary to methyl n-butyl ketone. Conn Med. 1976 May;40(5):311–312. [PubMed] [Google Scholar]
  84. Yamamura Y. n-Hexane polyneuropathy. Folia Psychiatr Neurol Jpn. 1969;23(1):45–57. doi: 10.1111/j.1440-1819.1969.tb01441.x. [DOI] [PubMed] [Google Scholar]
  85. de la Burdé B., Choate M. L. Early asymptomatic lead exposure and development at school age. J Pediatr. 1975 Oct;87(4):638–642. doi: 10.1016/s0022-3476(75)80845-6. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES